首页 > 最新文献

Klinicka mikrobiologie a infekcni lekarstvi最新文献

英文 中文
[Occurrence of methicillin-resistant Staphylococcus aureus strains at the University Hospital Olomouc]. [奥洛穆茨大学医院耐甲氧西林金黄色葡萄球菌菌株的发生]。
Q3 Medicine Pub Date : 2024-03-01
Kateřina Fišerová, Miroslava Htoutou Sedláková, Vendula Pudová, Kristýna Hricová, Milan Kolář

Objective: This study aimed to evaluate the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) at the University Hospital Olomouc (UHO) over a 10-year period (2013-2022).

Material and methods: Data was obtained from the ENVIS LIMS laboratory information system (DS Soft, Czech Republic, Olomouc) of the Department of Microbiology, UHO, for the period 1/1/2013-31/12/2022. Standard microbiological procedures using the MALDI-TOF MS system (Biotyper Microflex, Bruker Daltonics) were applied for the identification. Antimicrobial susceptibility was determined by the standard broth microdilution method according to EUCAST criteria. All Staphylococcus aureus strains were tested for methicillin resistance using selective diagnostic chromogenic media (ColorexTMMRSA, TRIOS) and an immunochromatographic test for PBP2a detection (PBP2a SA Culture Colony Test, AlereTM). Positive results were confirmed by mecA gene detection. Molecular typing to determine clonality/relatedness was performed on isolates from 2022 using pulsed-field gel electrophoresis (PFGE).

Results: The prevalence of MRSA at the UHO does not show an increasing trend and ranges between 3-6 %. The highest MRSA prevalence was detected in blood culture specimens (6 %), followed by lower respiratory tract specimens (5 %) and wound/abscess/aspirate specimens (5 %). The departments with the highest MRSA prevalence were the Geriatrics Department and the Second Internal Medicine Department. The antibiotic resistance patterns of MRSA were as follows: erythromycin 89 %, clindamycin 86 %, ciprofloxacin 80%, tetracycline 18 %, gentamicin 13 %, cotrimoxazole 7 %, and tigecycline 1 %. Resistance to antibiotics of choice for serious MRSA infections (vancomycin, ceftaroline, linezolid) was 0-1 %. Genetic analysis of selected MRSA isolates by PFGE revealed one cluster of five, two clusters of three, and two clusters of two isolates with indistinguishable restriction profiles.

Conclusion: The prevalence of MRSA at the UHO remains low, therefore oxacillin or possibly combined aminopenicillins (amoxicillin/clavulanic acid and ampicillin/sulbactam) or cefazolin can be relied upon for initial therapy of infections likely caused by Staphylococcus aureus.

目的:本研究旨在评估奥洛穆茨大学医院(UHO) 10年间(2013-2022)耐甲氧西林金黄色葡萄球菌(MRSA)的发生情况。材料和方法:数据来自世界卫生组织微生物学系ENVIS LIMS实验室信息系统(DS Soft, Czech Republic, Olomouc),时间为2013年1月1日- 2022年12月31日。使用MALDI-TOF质谱系统(Biotyper Microflex, Bruker Daltonics)的标准微生物学程序进行鉴定。采用标准肉汤微量稀释法,按EUCAST标准测定药敏度。采用选择性诊断显色培养基(ColorexTMMRSA, TRIOS)和PBP2a检测免疫层析试验(PBP2a SA培养菌落试验,AlereTM)检测所有金黄色葡萄球菌菌株的甲氧西林耐药性。mecA基因检测证实阳性。使用脉冲场凝胶电泳(PFGE)对2022年分离的菌株进行分子分型以确定克隆/亲缘性。结果:MRSA在who的流行率没有上升趋势,在3- 6%之间。MRSA感染率最高的是血培养标本(6%),其次是下呼吸道标本(5%)和伤口/脓肿/抽吸标本(5%)。MRSA患病率最高的科室为老年科和第二内科。MRSA的耐药模式为:红霉素89%,克林霉素86%,环丙沙星80%,四环素18%,庆大霉素13%,复方新诺明7%,替加环素1%。对严重MRSA感染所选择的抗生素(万古霉素、头孢他林、利奈唑胺)的耐药性为0- 1%。通过PFGE对选定的MRSA分离株进行遗传分析,发现1簇5个,2簇3个,2簇2个分离株具有难以区分的限制性基因图谱。结论:世界卫生组织MRSA的流行率仍然很低,因此对于可能由金黄色葡萄球菌引起的感染,可依赖于oxacillin或可能联合氨霉素(阿莫西林/克拉维酸和氨苄西林/舒巴坦)或头孢唑林进行初始治疗。
{"title":"[Occurrence of methicillin-resistant Staphylococcus aureus strains at the University Hospital Olomouc].","authors":"Kateřina Fišerová, Miroslava Htoutou Sedláková, Vendula Pudová, Kristýna Hricová, Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) at the University Hospital Olomouc (UHO) over a 10-year period (2013-2022).</p><p><strong>Material and methods: </strong>Data was obtained from the ENVIS LIMS laboratory information system (DS Soft, Czech Republic, Olomouc) of the Department of Microbiology, UHO, for the period 1/1/2013-31/12/2022. Standard microbiological procedures using the MALDI-TOF MS system (Biotyper Microflex, Bruker Daltonics) were applied for the identification. Antimicrobial susceptibility was determined by the standard broth microdilution method according to EUCAST criteria. All Staphylococcus aureus strains were tested for methicillin resistance using selective diagnostic chromogenic media (ColorexTMMRSA, TRIOS) and an immunochromatographic test for PBP2a detection (PBP2a SA Culture Colony Test, AlereTM). Positive results were confirmed by mecA gene detection. Molecular typing to determine clonality/relatedness was performed on isolates from 2022 using pulsed-field gel electrophoresis (PFGE).</p><p><strong>Results: </strong>The prevalence of MRSA at the UHO does not show an increasing trend and ranges between 3-6 %. The highest MRSA prevalence was detected in blood culture specimens (6 %), followed by lower respiratory tract specimens (5 %) and wound/abscess/aspirate specimens (5 %). The departments with the highest MRSA prevalence were the Geriatrics Department and the Second Internal Medicine Department. The antibiotic resistance patterns of MRSA were as follows: erythromycin 89 %, clindamycin 86 %, ciprofloxacin 80%, tetracycline 18 %, gentamicin 13 %, cotrimoxazole 7 %, and tigecycline 1 %. Resistance to antibiotics of choice for serious MRSA infections (vancomycin, ceftaroline, linezolid) was 0-1 %. Genetic analysis of selected MRSA isolates by PFGE revealed one cluster of five, two clusters of three, and two clusters of two isolates with indistinguishable restriction profiles.</p><p><strong>Conclusion: </strong>The prevalence of MRSA at the UHO remains low, therefore oxacillin or possibly combined aminopenicillins (amoxicillin/clavulanic acid and ampicillin/sulbactam) or cefazolin can be relied upon for initial therapy of infections likely caused by Staphylococcus aureus.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"30 1","pages":"4-10"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparing standard microbiological methods for identification of Staphylococcus aureus and MRSA with the automated BD MAXTM StaphSR system]. [与全自动BD MAXTM StaphSR系统比较鉴定金黄色葡萄球菌和MRSA的标准微生物学方法]。
Q3 Medicine Pub Date : 2024-03-01
Kristýna Hricová, Vendula Pudová, Kristýna Fišerová, Miroslava Htoutou Sedláková, Milan Kolář

Objectives: Staphylococcus aureus is part of the human microbiota, but at the same time, it is capable of causing a wide range of diseases. Due to the ever-increasing resistance to antimicrobial agents and the existence of methicillin-resistant S. aureus (MRSA) strains, there is a real possibility of carrying even this resistant bacterium, which can subsequently cause a severe infection. MRSA detection is part of microbiological examination procedures, and it is appropriate to use rapid methods for its identification, especially in high-risk patients.

Material and methods: Clinical samples from the respiratory tract of patients from the Department of Anesthesiology, Resuscitation and Intensive Medicine, and the Third Internal Medicine Department of the University Hospital Olomouc were included in this study. These were processed simultaneously using standard microbiological methods and the automated BD MAXTM system, designed for qualitative detection of bacteria directly from clinical samples using real-time PCR.

Results: Standard microbiological methods identified S. aureus in 7 % and MRSA in 1 % of respiratory samples tested. Using the automated BD MAXTM system with the StaphSR kit, S. aureus DNA was detected in 28 % of samples and MRSA DNA in 2 % of samples.

Conclusion: Direct testing of clinical samples using the BD MAXTM StaphSR system can aid in the prevention and control of infections caused by S. aureus and MRSA, especially in healthcare facilities. An important advantage of this system is that the result is available on the same day that the clinical material is delivered for microbiological testing.

目的:金黄色葡萄球菌是人类微生物群的一部分,但同时,它能够引起广泛的疾病。由于对抗菌剂的耐药性不断增加以及耐甲氧西林金黄色葡萄球菌(MRSA)菌株的存在,甚至有可能携带这种耐药细菌,从而导致严重感染。MRSA检测是微生物学检查程序的一部分,使用快速方法进行鉴定是适当的,特别是在高危患者中。材料与方法:选取奥洛穆茨大学附属医院麻醉、复苏与重症医学科及内科第三科患者呼吸道临床样本。采用标准微生物学方法和全自动BD MAXTM系统同时进行处理,该系统专为使用实时PCR直接从临床样品中定性检测细菌而设计。结果:标准微生物学方法检测出7%的呼吸道样本中有金黄色葡萄球菌,1%的呼吸道样本中有MRSA。使用带有StaphSR试剂盒的自动化BD MAXTM系统,在28%的样品中检测到金黄色葡萄球菌DNA,在2%的样品中检测到MRSA DNA。结论:采用BD MAXTM StaphSR系统对临床样品进行直接检测有助于预防和控制金黄色葡萄球菌和MRSA引起的感染,特别是在医疗机构。该系统的一个重要优点是,结果可以在临床材料交付进行微生物测试的同一天获得。
{"title":"[Comparing standard microbiological methods for identification of Staphylococcus aureus and MRSA with the automated BD MAXTM StaphSR system].","authors":"Kristýna Hricová, Vendula Pudová, Kristýna Fišerová, Miroslava Htoutou Sedláková, Milan Kolář","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>Staphylococcus aureus is part of the human microbiota, but at the same time, it is capable of causing a wide range of diseases. Due to the ever-increasing resistance to antimicrobial agents and the existence of methicillin-resistant S. aureus (MRSA) strains, there is a real possibility of carrying even this resistant bacterium, which can subsequently cause a severe infection. MRSA detection is part of microbiological examination procedures, and it is appropriate to use rapid methods for its identification, especially in high-risk patients.</p><p><strong>Material and methods: </strong>Clinical samples from the respiratory tract of patients from the Department of Anesthesiology, Resuscitation and Intensive Medicine, and the Third Internal Medicine Department of the University Hospital Olomouc were included in this study. These were processed simultaneously using standard microbiological methods and the automated BD MAXTM system, designed for qualitative detection of bacteria directly from clinical samples using real-time PCR.</p><p><strong>Results: </strong>Standard microbiological methods identified S. aureus in 7 % and MRSA in 1 % of respiratory samples tested. Using the automated BD MAXTM system with the StaphSR kit, S. aureus DNA was detected in 28 % of samples and MRSA DNA in 2 % of samples.</p><p><strong>Conclusion: </strong>Direct testing of clinical samples using the BD MAXTM StaphSR system can aid in the prevention and control of infections caused by S. aureus and MRSA, especially in healthcare facilities. An important advantage of this system is that the result is available on the same day that the clinical material is delivered for microbiological testing.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"30 1","pages":"11-14"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sepsis caused by Pasteurella multocida after a dog bite]. [狗咬伤后由多杀性巴氏杆菌引起的败血症]。
Q3 Medicine Pub Date : 2024-03-01
Jana Pavličíková

This article reports a case of systemic infection caused by Pasteurella multocida. The infection was confirmed in a 79-year-old man who was admitted to the hospital after falling from a couch. The disease was manifested by the development of fever, chills, joint pain. Laboratory tests revealed elevated C-reactive protein levels, slightly elevated nitrogen metabolites, borderline leukocytosis, and thrombocytopenia. The pathogen was identified in a blood culture and a wound swab culture. The patient was initially treated with third-generation cephalosporin (cefotaxime) and later with cefuroxime. The article is supplemented with information on the etiologic agent, its history, and a literature review of documented complicated cases of pasteurellosis.

本文报告一例由多杀性巴氏杆菌引起的全身感染。一名79岁的男子在从沙发上摔下来后被送入医院。本病表现为发热、寒战、关节痛。实验室检查显示c反应蛋白水平升高,氮代谢物轻度升高,边缘性白细胞增多和血小板减少。在血液培养和伤口拭子培养中鉴定出病原体。患者最初使用第三代头孢菌素(头孢噻肟),后来使用头孢呋辛。文章补充了病原,其历史的信息,并文献回顾记录复杂的病例巴氏杆菌病。
{"title":"[Sepsis caused by Pasteurella multocida after a dog bite].","authors":"Jana Pavličíková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This article reports a case of systemic infection caused by Pasteurella multocida. The infection was confirmed in a 79-year-old man who was admitted to the hospital after falling from a couch. The disease was manifested by the development of fever, chills, joint pain. Laboratory tests revealed elevated C-reactive protein levels, slightly elevated nitrogen metabolites, borderline leukocytosis, and thrombocytopenia. The pathogen was identified in a blood culture and a wound swab culture. The patient was initially treated with third-generation cephalosporin (cefotaxime) and later with cefuroxime. The article is supplemented with information on the etiologic agent, its history, and a literature review of documented complicated cases of pasteurellosis.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"30 1","pages":"22-26"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of enzybiotics on the healing of Staphylococcus aureus-infected skin wounds in a pig model]. [酶制剂对猪模型金黄色葡萄球菌感染皮肤伤口愈合的影响]。
Q3 Medicine Pub Date : 2024-03-01
Peter Makovický, BřetislavMilena Lipový, Edita Jeklová, Filip Raška, Mária Makovická, Šárka Kobzová, Adam Norek, Lubomír Janda

Introduction: Staphylococcus aureus is a gram-positive, facultatively anaerobic coccus capable of causing infectious diseases in animals and humans. Especially dangerous are multidrug-resistant forms with poor or even no response to available treatments.

Objectives: The study aimed to verify the effect of enzybiotics on the healing of S. aureus-infected skin wounds in an experimental pig model.

Methodology: Two pigs were included in the experiment and wounds (10/pig) of 5 × 5 cm in size with 2 cm spacing were made by incision on their backs. The wounds were infected with a methicillin (oxacillin) and amoxicillin-resistant strain of S. aureus (MRSA). The experimental groups consisted of individual wounds that were infected with one sequence type of S. aureus at a concentration of 2 × 109 CFU/mL. Two wounds were left untreated (N), four wounds were using hydrogel with added lysostaphin, and four wounds were treated using hydrogel with added lysostaphin and endolysin. Subsequently, samples were taken from each wound on days 4, 7, 11, and 14. The material was processed using a standard histological technique of paraffin blocks and the sections were stained with hematoxylineosin.

Results: The results show that these defects present a full spectrum of reparative changes with re-epithelialization with alternating sections of necrosis and newly formed granulation tissue with an accompanying round cell inflammatory infiltrate in edematous tissue and surface scabs. On the surface of the wounds and also in smaller groups in the newly formed granulation tissue, coccoid formations corresponding to S. aureus are visible. Compared to untreated wounds, hydrogel dressings with added lysostaphin or lysostaphin and endolysin trapped greater numbers of S. aureus cocci colonies, which subsequently died off to a large extent.

Conclusion: Enzybiotics may have interesting potential in the topical therapy of MRSA-infected skin wounds.

简介:金黄色葡萄球菌是一种革兰氏阳性的兼性厌氧球菌,能够引起动物和人类的传染病。尤其危险的是对现有治疗反应差甚至没有反应的耐多药菌株。目的:在实验猪模型上验证酶制剂对金黄色葡萄球菌感染皮肤伤口愈合的影响。方法:实验选用2头猪,在猪背上切开5 × 5 cm大小的伤口(10头/头),切口间距2 cm。伤口感染甲氧西林(oxacillin)和耐阿莫西林金黄色葡萄球菌(MRSA)菌株。实验组为单个伤口感染1种序列型金黄色葡萄球菌,浓度为2 × 109 CFU/mL。2个创面未处理(N), 4个创面使用添加溶葡萄球菌蛋白的水凝胶,4个创面使用添加溶葡萄球菌蛋白和内溶素的水凝胶。随后,在第4、7、11和14天分别从每个伤口采集样本。该材料采用石蜡块标准组织学技术处理,切片用苏木精染色。结果:结果表明,这些缺陷表现出全方位的修复性改变,包括再上皮化,坏死和新形成的肉芽组织交替切片,并伴有水肿组织和表面结痂的圆形细胞炎症浸润。在伤口表面以及在新形成的肉芽组织中,可以看到与金黄色葡萄球菌相对应的球粒状结构。与未经处理的伤口相比,添加溶葡萄球菌素或溶葡萄球菌素和内溶菌素的水凝胶敷料捕获了更多的金黄色葡萄球菌菌落,这些菌落随后在很大程度上死亡。结论:酶制剂在耐甲氧西林金黄色葡萄球菌感染皮肤创面的局部治疗中具有重要的应用前景。
{"title":"[Effect of enzybiotics on the healing of Staphylococcus aureus-infected skin wounds in a pig model].","authors":"Peter Makovický, BřetislavMilena Lipový, Edita Jeklová, Filip Raška, Mária Makovická, Šárka Kobzová, Adam Norek, Lubomír Janda","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Staphylococcus aureus is a gram-positive, facultatively anaerobic coccus capable of causing infectious diseases in animals and humans. Especially dangerous are multidrug-resistant forms with poor or even no response to available treatments.</p><p><strong>Objectives: </strong>The study aimed to verify the effect of enzybiotics on the healing of S. aureus-infected skin wounds in an experimental pig model.</p><p><strong>Methodology: </strong>Two pigs were included in the experiment and wounds (10/pig) of 5 × 5 cm in size with 2 cm spacing were made by incision on their backs. The wounds were infected with a methicillin (oxacillin) and amoxicillin-resistant strain of S. aureus (MRSA). The experimental groups consisted of individual wounds that were infected with one sequence type of S. aureus at a concentration of 2 × 109 CFU/mL. Two wounds were left untreated (N), four wounds were using hydrogel with added lysostaphin, and four wounds were treated using hydrogel with added lysostaphin and endolysin. Subsequently, samples were taken from each wound on days 4, 7, 11, and 14. The material was processed using a standard histological technique of paraffin blocks and the sections were stained with hematoxylineosin.</p><p><strong>Results: </strong>The results show that these defects present a full spectrum of reparative changes with re-epithelialization with alternating sections of necrosis and newly formed granulation tissue with an accompanying round cell inflammatory infiltrate in edematous tissue and surface scabs. On the surface of the wounds and also in smaller groups in the newly formed granulation tissue, coccoid formations corresponding to S. aureus are visible. Compared to untreated wounds, hydrogel dressings with added lysostaphin or lysostaphin and endolysin trapped greater numbers of S. aureus cocci colonies, which subsequently died off to a large extent.</p><p><strong>Conclusion: </strong>Enzybiotics may have interesting potential in the topical therapy of MRSA-infected skin wounds.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"30 1","pages":"15-21"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bacteremic purulent knee arthritis caused by a non-toxigenic strain of Corynebacterium diphtheriae]. [由白喉棒状杆菌非产毒株引起的细菌性化脓性膝关节炎]。
Q3 Medicine Pub Date : 2023-09-01
Kostiantyn Istomin, Magda Balejová, Eva Dvořáková, David Musil, Jan Klouda, Aleš Chrdle

Corynebacteria, non-spore-forming, gram-positive, aerobic or facultative anaerobic, pleomorphic bacilli, are part of the normal skin, oropharyngeal, and intestinal flora in humans. However, this microorganism can rarely be associated with invasive infections such as bone and joint infections, bacteremia, endocarditis, meningitis, liver and spleen abscesses. We present a case of bacteremic arthritis of a native knee joint caused by non-toxigenic Corynebacterium diphtheriae in a patient with alcoholic liver cirrhosis. This case report emphasizes the importance of differential diagnosis and careful examination of immunocompromised patients and reviews the criteria for administration of C. diphtheriae antitoxin in case of invasive disease.

棒状杆菌,非孢子形成,革兰氏阳性,需氧或兼性厌氧,多形性杆菌,是人类正常皮肤,口咽和肠道菌群的一部分。然而,这种微生物很少与侵袭性感染有关,如骨和关节感染、菌血症、心内膜炎、脑膜炎、肝和脾脓肿。我们提出一个病例细菌性关节炎的原生膝关节引起的非产毒素白喉杆杆菌患者酒精性肝硬化。本病例报告强调了鉴别诊断和免疫功能低下患者仔细检查的重要性,并回顾了在侵袭性疾病情况下给予白喉白喉抗毒素的标准。
{"title":"[Bacteremic purulent knee arthritis caused by a non-toxigenic strain of Corynebacterium diphtheriae].","authors":"Kostiantyn Istomin, Magda Balejová, Eva Dvořáková, David Musil, Jan Klouda, Aleš Chrdle","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Corynebacteria, non-spore-forming, gram-positive, aerobic or facultative anaerobic, pleomorphic bacilli, are part of the normal skin, oropharyngeal, and intestinal flora in humans. However, this microorganism can rarely be associated with invasive infections such as bone and joint infections, bacteremia, endocarditis, meningitis, liver and spleen abscesses. We present a case of bacteremic arthritis of a native knee joint caused by non-toxigenic Corynebacterium diphtheriae in a patient with alcoholic liver cirrhosis. This case report emphasizes the importance of differential diagnosis and careful examination of immunocompromised patients and reviews the criteria for administration of C. diphtheriae antitoxin in case of invasive disease.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 3","pages":"88-91"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pneumocystis pneumonia]. 肺孢子菌肺炎。
Q3 Medicine Pub Date : 2023-09-01
Svatava Snopková, Radek Svačinka, David Vydrář, Petr Husa, Tereza Kopřivová, Jakub Vlažný, Petr Husa

In parallel with the introduction of modern therapeutic and pharmacological interventions that have successfully resolved many diseases and conditions, previously deemed incompatible with life, there has been a significant increase in the number of patients experiencing secondary immunodeficiency. As a result, these patients are highly susceptible to various opportunistic infections. Among these infections, pneumocystis pneumonia (PCP) stands out as one of the most frequent and potentially life-threatening ones, necessitating prompt diagnosis and treatment. Observational studies have clearly shown that PCP affects an increasing number of patients with diverse underlying diseases and varying risk profiles that lead to immune system dysfunction. The population of at-risk patients and the range of these conditions continue to expand. Surprisingly, the diagnosis is now established in populations that were not initially considered at risk, such as patients on chronic glucocorticoid therapy. This disease often remains undiagnosed and contributes to a relatively high number of fatal outcomes in patients with various primary diseases. The text summarizes the basic epidemiological factors, risk factors, presumed pathophysiology, current diagnostic options, and typical clinical course of PCP in patients living with HIV and non-HIV patients, as well as the prophylaxis and treatment of PCP. It is important to note that in most patients with severe immunodeficiency, multiple agents are involved simultaneously in causing infectious complications. Coinfection with cytomegalovirus is a very common complication of PCP. In the context of multiple infections occurring simultaneously, if a coinfection goes unrecognized and untreated, it can render the treatment of PCP seemingly ineffective. Therefore, it is crucial to pay attention to potential coinfections already during the primary diagnosis.

在引进现代治疗和药理学干预措施,成功地解决了许多以前被认为与生命不相容的疾病和病症的同时,患有继发性免疫缺陷的患者人数也显著增加。因此,这些病人极易受到各种机会性感染。在这些感染中,肺囊虫性肺炎(PCP)是最常见和可能危及生命的感染之一,需要及时诊断和治疗。观察性研究清楚地表明,PCP影响越来越多的具有各种潜在疾病和导致免疫系统功能障碍的不同风险特征的患者。高危患者的人数和这些疾病的范围继续扩大。令人惊讶的是,这种诊断现在被建立在最初不被认为有风险的人群中,例如接受慢性糖皮质激素治疗的患者。这种疾病通常未被诊断,并导致各种原发疾病患者相对较高的致命结果。本文综述了HIV感染者和非HIV感染者PCP的基本流行病学因素、危险因素、推测的病理生理学、目前的诊断选择、PCP的典型临床病程,以及PCP的预防和治疗。值得注意的是,在大多数严重免疫缺陷患者中,多种药物同时参与引起感染性并发症。巨细胞病毒合并感染是PCP的常见并发症。在多重感染同时发生的情况下,如果合并感染未被识别和治疗,则可能使PCP的治疗看起来无效。因此,在初步诊断时注意潜在的合并感染是至关重要的。
{"title":"[Pneumocystis pneumonia].","authors":"Svatava Snopková, Radek Svačinka, David Vydrář, Petr Husa, Tereza Kopřivová, Jakub Vlažný, Petr Husa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In parallel with the introduction of modern therapeutic and pharmacological interventions that have successfully resolved many diseases and conditions, previously deemed incompatible with life, there has been a significant increase in the number of patients experiencing secondary immunodeficiency. As a result, these patients are highly susceptible to various opportunistic infections. Among these infections, pneumocystis pneumonia (PCP) stands out as one of the most frequent and potentially life-threatening ones, necessitating prompt diagnosis and treatment. Observational studies have clearly shown that PCP affects an increasing number of patients with diverse underlying diseases and varying risk profiles that lead to immune system dysfunction. The population of at-risk patients and the range of these conditions continue to expand. Surprisingly, the diagnosis is now established in populations that were not initially considered at risk, such as patients on chronic glucocorticoid therapy. This disease often remains undiagnosed and contributes to a relatively high number of fatal outcomes in patients with various primary diseases. The text summarizes the basic epidemiological factors, risk factors, presumed pathophysiology, current diagnostic options, and typical clinical course of PCP in patients living with HIV and non-HIV patients, as well as the prophylaxis and treatment of PCP. It is important to note that in most patients with severe immunodeficiency, multiple agents are involved simultaneously in causing infectious complications. Coinfection with cytomegalovirus is a very common complication of PCP. In the context of multiple infections occurring simultaneously, if a coinfection goes unrecognized and untreated, it can render the treatment of PCP seemingly ineffective. Therefore, it is crucial to pay attention to potential coinfections already during the primary diagnosis.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 3","pages":"69-79"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cytomegalovirus coinfection]. 巨细胞病毒合并感染。
Q3 Medicine Pub Date : 2023-09-01
Svatava Snopková, Radek Svačinka, David Vydrář, Petr Husa, Tereza Kopřivová, Jakub Vlažný, Petr Husa

The rapid advancement of modern pharmacological and surgical therapeutic interventions is often accompanied by potential disruptions to the immune system, both permanent and transient. Consequently, life-threatening infectious complications may emerge, which were either absent or exceedingly rare in the past. Observational studies have identified pneumocystis and cytomegalovirus pneumonia as one of the most prevalent coinfections. These diseases carry a high risk of a fatal course, making rapid and precise diagnosis and treatment absolutely crucial. Diagnostic and therapeutic procedures for coinfection with pneumocystis and cytomegalovirus pneumonia are based on empirical knowledge obtained from certain categories of patients and subsequently extrapolated to other categories. In cases where the immune system is dysfunctional, a significantly longer time interval is required before the effect of treatment becomes evident. Therefore, the treatment must be sufficiently prolonged compared to immunocompetent patients and administered with relatively high drug doses. The text highlights the fundamental epidemiological, clinical, diagnostic, and therapeutic aspects. We have attempted to address the questions that arose when confronted with similar situations, often facing ambiguous answers due to the lack of precisely documented data. With the increasing number of immunocompromised patients, particularly in countries with advanced healthcare systems, it becomes evident that the future will require the widespread availability of modern diagnostic methods and the development of drugs with significantly improved safety profiles. These advancements would enable extensive prophylaxis for at-risk patients.

现代药物和外科治疗干预的快速发展往往伴随着对免疫系统的潜在破坏,无论是永久的还是短暂的。因此,可能出现危及生命的感染性并发症,这些并发症在过去要么没有,要么极其罕见。观察性研究已经确定肺囊虫病和巨细胞病毒肺炎是最常见的合并感染之一。这些疾病具有很高的致命风险,因此迅速和准确的诊断和治疗绝对至关重要。肺囊虫病和巨细胞病毒肺炎合并感染的诊断和治疗程序是基于从某些类别的患者获得的经验知识,然后推断到其他类别。在免疫系统功能失调的情况下,在治疗效果显现之前需要明显较长的时间间隔。因此,与免疫功能正常的患者相比,治疗必须足够延长,并给予相对较高的药物剂量。文本强调了基本的流行病学,临床,诊断和治疗方面。我们试图解决在遇到类似情况时出现的问题,由于缺乏精确记录的数据,这些问题往往面临模棱两可的答案。随着免疫功能低下患者数量的增加,特别是在医疗保健系统先进的国家,很明显,未来将需要广泛使用现代诊断方法和开发安全性显著提高的药物。这些进步将使高危患者能够得到广泛的预防。
{"title":"[Cytomegalovirus coinfection].","authors":"Svatava Snopková, Radek Svačinka, David Vydrář, Petr Husa, Tereza Kopřivová, Jakub Vlažný, Petr Husa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The rapid advancement of modern pharmacological and surgical therapeutic interventions is often accompanied by potential disruptions to the immune system, both permanent and transient. Consequently, life-threatening infectious complications may emerge, which were either absent or exceedingly rare in the past. Observational studies have identified pneumocystis and cytomegalovirus pneumonia as one of the most prevalent coinfections. These diseases carry a high risk of a fatal course, making rapid and precise diagnosis and treatment absolutely crucial. Diagnostic and therapeutic procedures for coinfection with pneumocystis and cytomegalovirus pneumonia are based on empirical knowledge obtained from certain categories of patients and subsequently extrapolated to other categories. In cases where the immune system is dysfunctional, a significantly longer time interval is required before the effect of treatment becomes evident. Therefore, the treatment must be sufficiently prolonged compared to immunocompetent patients and administered with relatively high drug doses. The text highlights the fundamental epidemiological, clinical, diagnostic, and therapeutic aspects. We have attempted to address the questions that arose when confronted with similar situations, often facing ambiguous answers due to the lack of precisely documented data. With the increasing number of immunocompromised patients, particularly in countries with advanced healthcare systems, it becomes evident that the future will require the widespread availability of modern diagnostic methods and the development of drugs with significantly improved safety profiles. These advancements would enable extensive prophylaxis for at-risk patients.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 3","pages":"80-87"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diagnosis and therapy of chronic hepatitis D: Czech national guideline]. 慢性丁型肝炎的诊断和治疗:捷克国家指南。
Q3 Medicine Pub Date : 2023-09-01
Petr Husa, Jan Šperl, Petr Urbánek, Soňa Fraňková, Pavel Dlouhý
<p><p>For the first time, a separate Czech guideline focuses exclusively on hepatitis D virus (HDV) infection. Until recently, HDV infection was only mentioned in guidelines concerning hepatitis B virus (HBV) infection, in chapters on HBV/HDV co-infection. The guideline is based on the July 2023 recommendations from the European Association for the Study of the Liver. HDV can either infect a susceptible host together with HBV (co-infection) or superinfect a person chronically infected with HBV. HBV/HDV coinfection usually leads to acute hepatitis with a wide clinical spectrum ranging from an asymptomatic course, to mild hepatitis, to acute liver failure. However, only a small proportion of cases (approximately 2%) progress to chronicity. In contrast, superinfection with HDV in patients with chronic HBV infection very often leads to severe acute hepatitis, which progresses to chronic hepatitis D (CHD) in up to 90% of cases and is associated with more severe chronic outcomes than HBV monoinfection. CHD has been shown to progress to liver cirrhosis more frequently and more rapidly than HBV monoinfection. Globally, an estimated 4.5-13% of HBsAg-positive individuals are infected with HDV, representing 12-72 million persons infected with HDV in absolute numbers. HDV infection is still rare in the Czech Republic, with at most a few dozen patients, almost exclusively foreigners coming from endemic areas, mainly from Mongolia and other Asian countries. With the increasing migration of people from endemic areas, the incidence and prevalence of hepatitis D in the country may increase rapidly. Experts estimate that the prevalence of HDV among HBsAg-positive patients in the Czech Republic is approximately 1%. Until 2020, interferon (IFN) α-based therapy was the only treatment option for CHD. Gradually, treatment with pegylated interferon (PEG-IFN) α proved to be more effective than treatment with conventional (standard) IFNα - 25% vs. 17% virological response at the end of 48 week of treatment. Subsequently, however, more than half of the successfully treated patients experienced a virological relapse. Extending the duration of PEG-IFNα treatment to two years did not increase treatment success, as shown by the results of most clinical trials. Bulevirtide (BLV) is a synthetic lipopeptide consisting of 47 amino acids from the preS1 domain of the large HBsAg protein, which binds to NTCP, thereby preventing HDV from entering hepatocytes. Clinical trials have evaluated the efficacy and safety of BLV treatment at doses of 2, 5 and 10 mg administered subcutaneously once daily, alone or in combination with PEG-IFNα. Since the optimal duration of BLV treatment has not yet been established, sustained virological response could not be assessed because BLV treatment was not discontinued in the studies. According to results of clinical trials, a higher dose of BLV (10 mg) provides no benefit compared to a dose of 2 mg once daily. In July 2020, BLV received conditional mar
捷克第一次单独制定了针对丁型肝炎病毒(HDV)感染的指南。直到最近,HDV感染只在乙型肝炎病毒(HBV)感染指南中提到,在HBV/HDV合并感染章节中。该指南是基于欧洲肝脏研究协会2023年7月的建议。乙型肝炎病毒既可以与乙型肝炎病毒一起感染易感宿主(合并感染),也可以与乙型肝炎病毒慢性感染者重叠感染。HBV/HDV合并感染通常导致急性肝炎,其临床范围广泛,从无症状到轻度肝炎,到急性肝衰竭。然而,只有一小部分病例(约2%)进展为慢性。相比之下,慢性HBV感染患者的HDV重复感染通常导致严重急性肝炎,在高达90%的病例中发展为慢性丁型肝炎(CHD),并且与HBV单一感染相比具有更严重的慢性结局。冠心病进展为肝硬化比HBV单感染更频繁和更快。在全球范围内,估计有4.5% -13%的hbsag阳性个体感染了HDV,即绝对数量上感染了HDV的人数为1200万至7200万人。HDV感染在捷克共和国仍然很少见,最多只有几十名患者,几乎都是来自流行地区的外国人,主要来自蒙古和其他亚洲国家。随着流行地区人口迁移的增加,该国丁型肝炎的发病率和流行率可能迅速增加。专家估计,捷克共和国hbsag阳性患者中HDV的流行率约为1%。直到2020年,以干扰素(IFN) α为基础的治疗是冠心病的唯一治疗选择。渐渐地,在48周的治疗结束时,聚乙二醇化干扰素(PEG-IFN) α治疗被证明比常规(标准)IFNα治疗更有效——25% vs 17%的病毒学应答。然而,随后,超过一半的成功治疗的患者经历了病毒学复发。大多数临床试验的结果表明,延长peg - ifn - α治疗时间至两年并没有增加治疗成功率。Bulevirtide (BLV)是一种合成的脂肽,由来自大HBsAg蛋白preS1结构域的47个氨基酸组成,它与NTCP结合,从而阻止HDV进入肝细胞。临床试验已经评估了每日1次、单独或与peg - ifn - α联合皮下注射剂量分别为2、5和10 mg的BLV治疗的有效性和安全性。由于BLV治疗的最佳持续时间尚未确定,因此无法评估持续的病毒学反应,因为研究中没有停止BLV治疗。根据临床试验的结果,与每天2毫克的剂量相比,更高剂量的BLV(10毫克)没有任何益处。2020年7月,BLV获得了欧洲药品管理局(ema)用于治疗冠心病和代偿性肝病的有条件上市许可,并建议继续以每日2mg的剂量治疗BLV,直到看到临床益处。条件上市许可于2023年7月改为标准上市许可。
{"title":"[Diagnosis and therapy of chronic hepatitis D: Czech national guideline].","authors":"Petr Husa, Jan Šperl, Petr Urbánek, Soňa Fraňková, Pavel Dlouhý","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;p&gt;For the first time, a separate Czech guideline focuses exclusively on hepatitis D virus (HDV) infection. Until recently, HDV infection was only mentioned in guidelines concerning hepatitis B virus (HBV) infection, in chapters on HBV/HDV co-infection. The guideline is based on the July 2023 recommendations from the European Association for the Study of the Liver. HDV can either infect a susceptible host together with HBV (co-infection) or superinfect a person chronically infected with HBV. HBV/HDV coinfection usually leads to acute hepatitis with a wide clinical spectrum ranging from an asymptomatic course, to mild hepatitis, to acute liver failure. However, only a small proportion of cases (approximately 2%) progress to chronicity. In contrast, superinfection with HDV in patients with chronic HBV infection very often leads to severe acute hepatitis, which progresses to chronic hepatitis D (CHD) in up to 90% of cases and is associated with more severe chronic outcomes than HBV monoinfection. CHD has been shown to progress to liver cirrhosis more frequently and more rapidly than HBV monoinfection. Globally, an estimated 4.5-13% of HBsAg-positive individuals are infected with HDV, representing 12-72 million persons infected with HDV in absolute numbers. HDV infection is still rare in the Czech Republic, with at most a few dozen patients, almost exclusively foreigners coming from endemic areas, mainly from Mongolia and other Asian countries. With the increasing migration of people from endemic areas, the incidence and prevalence of hepatitis D in the country may increase rapidly. Experts estimate that the prevalence of HDV among HBsAg-positive patients in the Czech Republic is approximately 1%. Until 2020, interferon (IFN) α-based therapy was the only treatment option for CHD. Gradually, treatment with pegylated interferon (PEG-IFN) α proved to be more effective than treatment with conventional (standard) IFNα - 25% vs. 17% virological response at the end of 48 week of treatment. Subsequently, however, more than half of the successfully treated patients experienced a virological relapse. Extending the duration of PEG-IFNα treatment to two years did not increase treatment success, as shown by the results of most clinical trials. Bulevirtide (BLV) is a synthetic lipopeptide consisting of 47 amino acids from the preS1 domain of the large HBsAg protein, which binds to NTCP, thereby preventing HDV from entering hepatocytes. Clinical trials have evaluated the efficacy and safety of BLV treatment at doses of 2, 5 and 10 mg administered subcutaneously once daily, alone or in combination with PEG-IFNα. Since the optimal duration of BLV treatment has not yet been established, sustained virological response could not be assessed because BLV treatment was not discontinued in the studies. According to results of clinical trials, a higher dose of BLV (10 mg) provides no benefit compared to a dose of 2 mg once daily. In July 2020, BLV received conditional mar","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 3","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[In vitro comparison of antibacterial efficacy of nonadherent antimicrobial dressings]. 非黏附抗菌敷料的体外抗菌效果比较。
Q3 Medicine Pub Date : 2023-06-01
Johana Kučerová, Vojtěch Mezera, Ivo Bureš

Objectives: The use of nonadherent dressings is part of care for chronic wounds. In this paper, we present the results of in vitro activity of several such dressings on bacteria most commonly found in chronic wounds.

Material and methods: Selected bacterial strains were isolated from chronic wounds of patients in Pardubice Hospital in the period from February to May 2022. The following dressings were tested: Inadine and Aqvidine, both containing povidone iodine, Bactigras containing chlorhexidine acetate and Xeroform containing bismuth tribromophenate. The zone of inhibition size and the ability to inhibit growth after dressing removal were evaluated.

Results: Inadine and Aqvidine had significantly larger zones of inhibition than Bactigras or Xeroform. We found no significant differences between Inadine and Aqvidine (except for Klebsiella pneumoniae) or between Bactigras and Xeroform (except for Streptococcus pyogenes). Inadine and Aqvidine were able to inhibit bacterial growth after dressing removal (except for Proteus mirabilis and Pseudomonas aeruginosa). Bactigras and Xeroform did not exhibit this ability, which was only observed for Streptococcus pyogenes after removal of Bactigras.

Conclusions: The dressings Inadine and Aqvidine containing povidone iodine were more effective than Bactigras and Xeroform against all species tested and their antibacterial activity against most strains persisted even after removal. These differences in antibacterial -efficacy should be considered when selecting wound dressings.

目的:使用非粘附敷料是慢性伤口护理的一部分。在本文中,我们提出了几种这种敷料对慢性伤口中最常见的细菌的体外活性的结果。材料与方法:选取2022年2 - 5月帕尔杜比采医院慢性伤口患者中分离的细菌菌株。测试了以下敷料:含有聚维酮碘的Inadine和aquvidine,含有醋酸氯己定的Bactigras和含有三溴苯酸铋的Xeroform。对去除敷料后的抑制区大小和抑制生长的能力进行了评价。结果:吲哚丁和阿维丁的抑制区明显大于巴氏菌素和赛罗酮。我们发现Inadine和Aqvidine(肺炎克雷伯菌除外)或Bactigras和Xeroform(化脓性链球菌除外)之间没有显著差异。除变形杆菌和铜绿假单胞菌外,Inadine和aquvidine均能抑制敷料去除后的细菌生长。Bactigras和Xeroform没有表现出这种能力,这只在去除Bactigras后的化脓性链球菌中观察到。结论:含聚维酮碘的Inadine和Aqvidine敷料对所有菌种的抑菌效果均优于Bactigras和Xeroform,且去除后对大部分菌种的抑菌活性仍保持不变。在选择伤口敷料时应考虑这些抗菌效果的差异。
{"title":"[In vitro comparison of antibacterial efficacy of nonadherent antimicrobial dressings].","authors":"Johana Kučerová, Vojtěch Mezera, Ivo Bureš","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The use of nonadherent dressings is part of care for chronic wounds. In this paper, we present the results of in vitro activity of several such dressings on bacteria most commonly found in chronic wounds.</p><p><strong>Material and methods: </strong>Selected bacterial strains were isolated from chronic wounds of patients in Pardubice Hospital in the period from February to May 2022. The following dressings were tested: Inadine and Aqvidine, both containing povidone iodine, Bactigras containing chlorhexidine acetate and Xeroform containing bismuth tribromophenate. The zone of inhibition size and the ability to inhibit growth after dressing removal were evaluated.</p><p><strong>Results: </strong>Inadine and Aqvidine had significantly larger zones of inhibition than Bactigras or Xeroform. We found no significant differences between Inadine and Aqvidine (except for Klebsiella pneumoniae) or between Bactigras and Xeroform (except for Streptococcus pyogenes). Inadine and Aqvidine were able to inhibit bacterial growth after dressing removal (except for Proteus mirabilis and Pseudomonas aeruginosa). Bactigras and Xeroform did not exhibit this ability, which was only observed for Streptococcus pyogenes after removal of Bactigras.</p><p><strong>Conclusions: </strong>The dressings Inadine and Aqvidine containing povidone iodine were more effective than Bactigras and Xeroform against all species tested and their antibacterial activity against most strains persisted even after removal. These differences in antibacterial -efficacy should be considered when selecting wound dressings.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 2","pages":"36-42"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prevalence and genotypes of methicillin-resistant Staphylococcus aureus (MRSA) in humans, animals and foods in the Czech Republic]. [捷克共和国人类、动物和食品中耐甲氧西林金黄色葡萄球菌(MRSA)的流行率和基因型]。
Q3 Medicine Pub Date : 2023-06-01
Renáta Karpíšková, Kristýna Brodíková, Ivana Koláčková

Methicillin-resistant Staphylococcus aureus (MRSA) strains are emerging zoonotic pathogens that are of importance not only to human but also to veterinary medicine. MRSA strains spread among humans and animals and can also be transmitted through foods. In this article, we provide a summary of the prevalence of MRSA in the Czech Republic, focusing on the One Health concept, which explores the relationships between human and animal health and the environment. This approach, together with collaboration between health professionals, veterinarians and public health experts, can provide valuable insights and help in preventing and controlling MRSA outbreaks.

耐甲氧西林金黄色葡萄球菌(MRSA)菌株是新兴的人畜共患病原体,不仅对人类而且对兽医学都很重要。耐甲氧西林金黄色葡萄球菌在人类和动物之间传播,也可以通过食物传播。在这篇文章中,我们总结了MRSA在捷克共和国的流行情况,重点是同一个健康概念,该概念探讨了人类和动物健康与环境之间的关系。这种方法加上卫生专业人员、兽医和公共卫生专家之间的合作,可以提供有价值的见解,并有助于预防和控制耐甲氧西林金黄色葡萄球菌的爆发。
{"title":"[Prevalence and genotypes of methicillin-resistant Staphylococcus aureus (MRSA) in humans, animals and foods in the Czech Republic].","authors":"Renáta Karpíšková, Kristýna Brodíková, Ivana Koláčková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Methicillin-resistant Staphylococcus aureus (MRSA) strains are emerging zoonotic pathogens that are of importance not only to human but also to veterinary medicine. MRSA strains spread among humans and animals and can also be transmitted through foods. In this article, we provide a summary of the prevalence of MRSA in the Czech Republic, focusing on the One Health concept, which explores the relationships between human and animal health and the environment. This approach, together with collaboration between health professionals, veterinarians and public health experts, can provide valuable insights and help in preventing and controlling MRSA outbreaks.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"29 2","pages":"43-45"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142977766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicka mikrobiologie a infekcni lekarstvi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1